Browse the Drug and Alcohol Findings magazine

Series on HEPATITIS C AND NEEDLE EXCHANGE 2750Kb PDF file

CLICK BLUE TITLES TO DOWNLOAD FULL TEXT PDF

Click the heading above for the full series or select from the parts listed below. The individual items may feature live links not available in the full series. The list shows the type of document, year published, the title (in blue), the size and type of file, and a brief description of the articles.
If you have not found what you want you could:
● Select another issue or series from the sidebar on the left or browse our archived bulletins.
● Try a subject or free text search instead. Searches include all the documents on this site.
● Return to the home page.

REVIEW 2003
Hepatitis C and needle exchange part 1: The dimensions of the challenge 1150Kb PDF file

First part of the series established that hepatitis C has already infected a substantial minority of British injectors and is spreading rapidly due to continued risk behaviour allied with the robustness, infectivity and prevalence of the virus.

REVIEW 2003
Hepatitis C and needle exchange part 2: case studies 1826Kb PDF file

Six case studies show how the complex balance of exchange services can be disrupted, leaving hepatitis C and HIV spreading rapidly. Common themes are resource starvation, local hostility, counterproductive restrictions and a non-interventionist ethic. Includes influential early studies dating from 1992.

REVIEW 2004
Hepatitis C and needle exchange part 3: the British record 784Kb PDF file

Reveals the paucity of evidence that exchanges in Britain have directly reduced risk behaviour or infection spread, and the hidden flaw in the seminal pilot study. Lack of real impact is probably less the problem than lack of real evidence of impact.

REVIEW 2004
Hepatitis C and needle exchange part 4: the active ingredients 1222Kb PDF file

Final part of the series pulls together the threads in the form of the limitations which threaten viral control and the practice ingredients which hold promise for the future. A revitalised agenda commensurate with the challenge of hepatitis C.